BIOLASE Granted New European Patent

BIOLASE Technology, a medical technology company focused primarily on dentistry and related specialties, has been granted a new European patent protecting key areas related to its core water and laser technology.

The patent, granted by the European Patent Office, has broad and complex claims related to the company's core technology of water and laser utilized in the Waterlase MD and Waterlase YSGG systems. The patent has been granted in 10 European countries, including Germany, France, the UK, Italy and Spain, which represent key markets for BIOLASE's Waterlase systems.

The scope of the patent claims is not only limited to technologies for cutting dental tissues, such as bone, dentin, enamel, cementum, gums, skin and mucosa, but also for cutting tissues related to medical applications, such as bone, cartilage, liver, kidney, brain, eye and vessels. Additionally, the patent's fluid conditioning claims cover medications, antiseptics, disinfectants and flavored fluids, which are applicable to both dental and medical applications.